Position in CLDX
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$2,945,729
+$1,226,823 QoQ
Shares Held
79,165
+46.1% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#91
of 252 holders
Holding Since
Dec 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALPS ADVISORS INC holds $213,436,831 across 115 Biotechnology names. CLDX ranks #20 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
315,335 | $17,680,833 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
62,523 | $8,298,677 | |
| 3 | CGON |
CG Oncology, Inc.
|
89,218 | $6,338,938 | |
| 4 | XENE |
Xenon Pharmaceuticals Inc.
|
97,610 | $5,891,739 | |
| 5 | ORKA |
Oruka Therapeutics, Inc.
|
61,014 | $5,806,702 | |
| 6 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
55,281 | $5,388,791 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
93,981 | $5,339,060 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
110,388 | $5,192,651 |
All Filings in CLDX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,945,729 | 79,165 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $1,718,906 | 54,190 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $1,481,822 | 54,559 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $825,666 | 31,916 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $728,774 | 35,812 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $906,374 | 49,938 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $1,355,735 | 53,650 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,721,831 | 50,657 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,902,276 | 51,399 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,907,116 | 45,440 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,493,000 | 37,645 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $959,016 | 34,848 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,178,558 | 34,735 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,119,157 | 31,105 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $1,423,966 | 31,949 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $718,491 | 25,560 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $747,870 | 27,740 | Shares | Defined | 2022-08-15 | |
| 2021-03-31 | $1,474,568 | 71,581 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $1,239,014 | 70,720 | Shares | Defined | 2021-02-03 | |
| No filing history on record for this holder in this stock. | ||||||